ArticleJournal of controlled release : official journal of the Controlled Release Society2025

PD-L1 targeted antibody-polymer-Epirubicin conjugate prolongs survival in a preclinical murine model of advanced ovarian cancer.

Jiahui Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.